# A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers

> **NCT03586726** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Balovaptan
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT03586726
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-24
- **Primary completion:** 2018-11-02
- **Final completion:** 2018-11-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03586726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03586726, "A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03586726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*